Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 7/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 3/20 | 0.39 |
| ▸ | DRD2 | P14416 | 2/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8115889 | 0.99 | HTR1A (0.40) | HTR1ASIGMAR1ALDH1A1HTR7DRD2 | |
| SCHEMBL7474002 | 0.88 | SIGMAR1 (0.53) | HTR1ASIGMAR1DRD2KDM4ECYP1A2 | |
| SCHEMBL8418004 | 0.86 | HTR1A (0.48) | HTR1AALDH1A1HTR7DRD2HTR2A | |
| SCHEMBL8113668 | 0.82 | ALDH1A1 (0.47) | HTR1AALDH1A1HTR7KDM4E | |
| Citric Acid SCHEMBL7477509 | 0.78 | HTR1A (0.43) | HTR1ASIGMAR1DRD2KDM4ECYP1A2 | |
| SCHEMBL8416472 | 0.77 | KDM4E (0.61) | HTR1AHTR7DRD2HTR2AKDM4E | |
| SCHEMBL8416503 | 0.77 | HTR1A (0.61) | HTR1ASIGMAR1ALDH1A1HTR7DRD2 | |
| SCHEMBL8416539 | 0.74 | HTR2A (0.55) | HTR1ASIGMAR1HTR7DRD2HTR2A | |
| SCHEMBL8418003 | 0.73 | HSD17B10 (0.56) | HTR1AHTR7DRD2HTR2A | |
| SCHEMBL8416455 | 0.72 | HTR1A (0.62) | HTR1AALDH1A1HTR7DRD2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0610140-B1 | 2-[4-(4-Azolylbutyl)-1-piperazinyl]-5-hydroxypyrimidin derivatives, their preparation and their use as medicines | ESTEVE LABOR DR (ES) | 2000-01-12 | — | — | EP | claimed |
| EP-0610140-A1 | 2- 4-(4-Azolylbutyl)-1-piperazinyl -5-hydroxypyrimidin derivatives, their preparation and their use als medicines | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 1994-08-10 | — | — | EP | claimed |
| EP-0610140-B1 | 2-[4-(4-Azolylbutyl)-1-piperazinyl]-5-hydroxypyrimidin derivatives, their preparation and their use as medicines | ESTEVE LABOR DR (ES) | 2000-01-12 | — | — | EP | disclosed |
| US-5444059-A | Anxiolytic agents | LABORATORIOS DEL. DR. ESTEVE, S.A. (ES) | 1995-08-22 | — | — | US | disclosed |
| EP-0610140-A1 | 2- 4-(4-Azolylbutyl)-1-piperazinyl -5-hydroxypyrimidin derivatives, their preparation and their use als medicines | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 1994-08-10 | — | — | EP | disclosed |